64 related articles for article (PubMed ID: 11299782)
1. Apoptosis-induction and phosphorylation state in human pancreatic carcinoma xenografts following octreotide treatment.
Zalatnai A; Pogány V
Anticancer Res; 2001; 21(1A):477-80. PubMed ID: 11299782
[TBL] [Abstract][Full Text] [Related]
2. Short-term octreotide treatment induces apoptosis in human pancreatic cancer xenografts.
Zalatnai A; Bocsi J
In Vivo; 2006; 20(4):549-52. PubMed ID: 16900788
[TBL] [Abstract][Full Text] [Related]
3. Flow cytometric evidence of apoptosis in human pancreatic cancer xenografts treated with Sandostatin (octreotide).
Zalatnai A; Szegedi Z; Bocsi J
Anticancer Res; 2000; 20(3A):1663-6. PubMed ID: 10928088
[TBL] [Abstract][Full Text] [Related]
4. Medroxyprogesterone acetate inhibits human pancreatic carcinoma cell growth by inducing apoptosis in association with Bcl-2 phosphorylation.
Abe M; Yamashita J; Ogawa M
Cancer; 2000 May; 88(9):2000-9. PubMed ID: 10813710
[TBL] [Abstract][Full Text] [Related]
5. Indirect antiproliferative effect of the somatostatin analog octreotide on MIA PaCa-2 human pancreatic carcinoma in nude mice.
Weckbecker G; Raulf F; Bodmer D; Bruns C
Yale J Biol Med; 1997; 70(5-6):549-54. PubMed ID: 9825482
[TBL] [Abstract][Full Text] [Related]
6. Mimosine, a plant-derived amino acid induces apoptosis in human pancreatic cancer xenografts.
Zalatnai A; Bocsi J
Anticancer Res; 2003; 23(5A):4007-9. PubMed ID: 14666710
[TBL] [Abstract][Full Text] [Related]
7. [Inhibition effects of octreotide on the growth of hepatocellular carcinoma in vitro and in vivo].
Wang C; Tang C; Tang L
Zhonghua Yi Xue Za Zhi; 2001 Oct; 81(19):1194-7. PubMed ID: 11769709
[TBL] [Abstract][Full Text] [Related]
8. Bcl-XL antisense oligonucleotides coupled with antennapedia enhances radiation-induced apoptosis in pancreatic cancer.
Masui T; Hosotani R; Ito D; Kami K; Koizumi M; Mori T; Toyoda E; Nakajima S; Miyamoto Y; Fujimoto K; Doi R
Surgery; 2006 Aug; 140(2):149-60. PubMed ID: 16904964
[TBL] [Abstract][Full Text] [Related]
9. [Inhibition of activator protein-1 on the growth of gastric cancer by octreotide].
Wang CH; Tang CW
Ai Zheng; 2002 Aug; 21(8):850-4. PubMed ID: 12478891
[TBL] [Abstract][Full Text] [Related]
10. Effect of SILA-409, a new organosilicon multidrug resistance modifier, on human pancreatic cancer xenografts.
Zalatnai A; Molnár J
In Vivo; 2006; 20(1):137-40. PubMed ID: 16433042
[TBL] [Abstract][Full Text] [Related]
11. Effect of octreotide on apoptosis-related proteins in rat Kupffer cells: a possible anti-tumour mechanism.
Xidakis C; Kolios G; Valatas V; Notas G; Mouzas I; Kouroumalis E
Anticancer Res; 2004; 24(2B):833-41. PubMed ID: 15161035
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic profile of the microtubule stabilizer patupilone in tumor-bearing rodents and comparison of anti-cancer activity with other MTS in vitro and in vivo.
O'Reilly T; Wartmann M; Brueggen J; Allegrini PR; Floersheimer A; Maira M; McSheehy PM
Cancer Chemother Pharmacol; 2008 Nov; 62(6):1045-54. PubMed ID: 18301895
[TBL] [Abstract][Full Text] [Related]
13. A novel subclass of thalidomide analogue with anti-solid tumor activity in which caspase-dependent apoptosis is associated with altered expression of bcl-2 family proteins.
Marriott JB; Clarke IA; Czajka A; Dredge K; Childs K; Man HW; Schafer P; Govinda S; Muller GW; Stirling DI; Dalgleish AG
Cancer Res; 2003 Feb; 63(3):593-9. PubMed ID: 12566301
[TBL] [Abstract][Full Text] [Related]
14. Effects of tumor necrosis factor-related apoptosis-inducing ligand alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice.
Itashiki Y; Harada K; Ferdous T; Yoshida H
Anticancer Res; 2007; 27(4B):2365-75. PubMed ID: 17695527
[TBL] [Abstract][Full Text] [Related]
15. Small molecule XIAP inhibitors enhance TRAIL-induced apoptosis and antitumor activity in preclinical models of pancreatic carcinoma.
Vogler M; Walczak H; Stadel D; Haas TL; Genze F; Jovanovic M; Bhanot U; Hasel C; Möller P; Gschwend JE; Simmet T; Debatin KM; Fulda S
Cancer Res; 2009 Mar; 69(6):2425-34. PubMed ID: 19258513
[TBL] [Abstract][Full Text] [Related]
16. Antineoplastic mechanism of Octreotide action in human hepatoma.
Chen X; Liu Z; Ai Z
Chin Med J (Engl); 2001 Nov; 114(11):1167-70. PubMed ID: 11729512
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of the nuclear factor-kappaB by lidamycin in association with inducing apoptosis in human pancreatic cancer cells and inhibiting xenograft growth.
Chen J; Ouyang ZG; Zhang SH; Zhen YS
Oncol Rep; 2007 Jun; 17(6):1445-51. PubMed ID: 17487403
[TBL] [Abstract][Full Text] [Related]
18. Effects of cepharanthine alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice.
Harada K; Ferdous T; Itashiki Y; Takii M; Mano T; Mori Y; Ueyama Y
Anticancer Res; 2009 Apr; 29(4):1263-70. PubMed ID: 19414373
[TBL] [Abstract][Full Text] [Related]
19. Somatostatin analogue octreotide and melatonin inhibit bromodeoxyuridine incorporation into cell nuclei and enhance apoptosis in the transplantable murine colon 38 cancer.
Mełen-Mucha G; Winczyk K; Pawlikowski M
Anticancer Res; 1998; 18(5A):3615-9. PubMed ID: 9858948
[TBL] [Abstract][Full Text] [Related]
20. Broad-spectrum G protein-coupled receptor antagonist, [D-Arg1,D-Trp5,7,9,Leu11]SP: a dual inhibitor of growth and angiogenesis in pancreatic cancer.
Guha S; Eibl G; Kisfalvi K; Fan RS; Burdick M; Reber H; Hines OJ; Strieter R; Rozengurt E
Cancer Res; 2005 Apr; 65(7):2738-45. PubMed ID: 15805273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
